Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017

Nidhi Gupta, Michael Rivera, Paul Novotny, Vilmarie Rodriguez, Irina Bancos, Aida Lteif

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background/Aims: Adrenocortical carcinoma (ACC) is an aggressive childhood cancer. Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenoma. The aim of this study was to investigate the clinicopathological data of children with ACC, identify prognostic factors, and validate a histopathological criterion to differentiate ACC from adrenocortical adenoma. Methods: This retrospective cohort included 41 children, followed at the Mayo Clinic from 1950 to 2017 (onset of symptoms ≤21 years). Outcomes of interest were: alive with no evidence of disease, alive with evidence of disease, and dead of disease. Results: Median age at onset of symptoms was 15.7 years (n = 41; range, 0.2–21 years). Female:male ratio was 3.6: 1. Mixed symptomatology (> 1 hormone abnormality) was the most common presentation (54%, n = 22). Sixty-six percent of patients (n = 27 out of 41) underwent total adrenalectomy. Metastatic disease was more common in children aged > 12 years (p = 0.002 compared to < 4 years). The most common sites of metastases were the liver and lungs. Overall 2-year and 5-year survival rates were 61% (95% CI 45–77) and 46% (95% CI 30–62), respectively. Metastasis at the time of diagnosis was independently associated with poor prognosis (risk ratio 13.7%; 95% CI 3.9–87.7). Weiss criteria (29%) and modified Weiss criteria (33%) were less accurate in younger patients (< 12 years), compared to the Wieneke index (100%). Conclusion: The presence of metastases was an independent prognostic factor. The Wieneke index was the most accurate in predicting clinical outcomes in younger children.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalHormone Research in Paediatrics
DOIs
StateAccepted/In press - May 25 2018

Fingerprint

Adrenocortical Carcinoma
Adrenocortical Adenoma
Neoplasm Metastasis
Adrenalectomy
Age of Onset
Survival Rate
Odds Ratio
Hormones
Lung
Liver
Neoplasms

Keywords

  • Adrenal tumor
  • Adrenalectomy
  • Child
  • Mitotane
  • Prognosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Adrenocortical Carcinoma in Children : A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017. / Gupta, Nidhi; Rivera, Michael; Novotny, Paul; Rodriguez, Vilmarie; Bancos, Irina; Lteif, Aida.

In: Hormone Research in Paediatrics, 25.05.2018, p. 1-11.

Research output: Contribution to journalArticle

Gupta, Nidhi ; Rivera, Michael ; Novotny, Paul ; Rodriguez, Vilmarie ; Bancos, Irina ; Lteif, Aida. / Adrenocortical Carcinoma in Children : A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017. In: Hormone Research in Paediatrics. 2018 ; pp. 1-11.
@article{857d9e00ecf44020ae89a1912711a278,
title = "Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017",
abstract = "Background/Aims: Adrenocortical carcinoma (ACC) is an aggressive childhood cancer. Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenoma. The aim of this study was to investigate the clinicopathological data of children with ACC, identify prognostic factors, and validate a histopathological criterion to differentiate ACC from adrenocortical adenoma. Methods: This retrospective cohort included 41 children, followed at the Mayo Clinic from 1950 to 2017 (onset of symptoms ≤21 years). Outcomes of interest were: alive with no evidence of disease, alive with evidence of disease, and dead of disease. Results: Median age at onset of symptoms was 15.7 years (n = 41; range, 0.2–21 years). Female:male ratio was 3.6: 1. Mixed symptomatology (> 1 hormone abnormality) was the most common presentation (54{\%}, n = 22). Sixty-six percent of patients (n = 27 out of 41) underwent total adrenalectomy. Metastatic disease was more common in children aged > 12 years (p = 0.002 compared to < 4 years). The most common sites of metastases were the liver and lungs. Overall 2-year and 5-year survival rates were 61{\%} (95{\%} CI 45–77) and 46{\%} (95{\%} CI 30–62), respectively. Metastasis at the time of diagnosis was independently associated with poor prognosis (risk ratio 13.7{\%}; 95{\%} CI 3.9–87.7). Weiss criteria (29{\%}) and modified Weiss criteria (33{\%}) were less accurate in younger patients (< 12 years), compared to the Wieneke index (100{\%}). Conclusion: The presence of metastases was an independent prognostic factor. The Wieneke index was the most accurate in predicting clinical outcomes in younger children.",
keywords = "Adrenal tumor, Adrenalectomy, Child, Mitotane, Prognosis",
author = "Nidhi Gupta and Michael Rivera and Paul Novotny and Vilmarie Rodriguez and Irina Bancos and Aida Lteif",
year = "2018",
month = "5",
day = "25",
doi = "10.1159/000488855",
language = "English (US)",
pages = "1--11",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Adrenocortical Carcinoma in Children

T2 - A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017

AU - Gupta, Nidhi

AU - Rivera, Michael

AU - Novotny, Paul

AU - Rodriguez, Vilmarie

AU - Bancos, Irina

AU - Lteif, Aida

PY - 2018/5/25

Y1 - 2018/5/25

N2 - Background/Aims: Adrenocortical carcinoma (ACC) is an aggressive childhood cancer. Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenoma. The aim of this study was to investigate the clinicopathological data of children with ACC, identify prognostic factors, and validate a histopathological criterion to differentiate ACC from adrenocortical adenoma. Methods: This retrospective cohort included 41 children, followed at the Mayo Clinic from 1950 to 2017 (onset of symptoms ≤21 years). Outcomes of interest were: alive with no evidence of disease, alive with evidence of disease, and dead of disease. Results: Median age at onset of symptoms was 15.7 years (n = 41; range, 0.2–21 years). Female:male ratio was 3.6: 1. Mixed symptomatology (> 1 hormone abnormality) was the most common presentation (54%, n = 22). Sixty-six percent of patients (n = 27 out of 41) underwent total adrenalectomy. Metastatic disease was more common in children aged > 12 years (p = 0.002 compared to < 4 years). The most common sites of metastases were the liver and lungs. Overall 2-year and 5-year survival rates were 61% (95% CI 45–77) and 46% (95% CI 30–62), respectively. Metastasis at the time of diagnosis was independently associated with poor prognosis (risk ratio 13.7%; 95% CI 3.9–87.7). Weiss criteria (29%) and modified Weiss criteria (33%) were less accurate in younger patients (< 12 years), compared to the Wieneke index (100%). Conclusion: The presence of metastases was an independent prognostic factor. The Wieneke index was the most accurate in predicting clinical outcomes in younger children.

AB - Background/Aims: Adrenocortical carcinoma (ACC) is an aggressive childhood cancer. Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenoma. The aim of this study was to investigate the clinicopathological data of children with ACC, identify prognostic factors, and validate a histopathological criterion to differentiate ACC from adrenocortical adenoma. Methods: This retrospective cohort included 41 children, followed at the Mayo Clinic from 1950 to 2017 (onset of symptoms ≤21 years). Outcomes of interest were: alive with no evidence of disease, alive with evidence of disease, and dead of disease. Results: Median age at onset of symptoms was 15.7 years (n = 41; range, 0.2–21 years). Female:male ratio was 3.6: 1. Mixed symptomatology (> 1 hormone abnormality) was the most common presentation (54%, n = 22). Sixty-six percent of patients (n = 27 out of 41) underwent total adrenalectomy. Metastatic disease was more common in children aged > 12 years (p = 0.002 compared to < 4 years). The most common sites of metastases were the liver and lungs. Overall 2-year and 5-year survival rates were 61% (95% CI 45–77) and 46% (95% CI 30–62), respectively. Metastasis at the time of diagnosis was independently associated with poor prognosis (risk ratio 13.7%; 95% CI 3.9–87.7). Weiss criteria (29%) and modified Weiss criteria (33%) were less accurate in younger patients (< 12 years), compared to the Wieneke index (100%). Conclusion: The presence of metastases was an independent prognostic factor. The Wieneke index was the most accurate in predicting clinical outcomes in younger children.

KW - Adrenal tumor

KW - Adrenalectomy

KW - Child

KW - Mitotane

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85047933033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047933033&partnerID=8YFLogxK

U2 - 10.1159/000488855

DO - 10.1159/000488855

M3 - Article

AN - SCOPUS:85047933033

SP - 1

EP - 11

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

ER -